Aug 2026· Aging Cell· Vol 25· 0 citations· 26 references
Medicine
TL;DR
Findings identify p16Ink4a‐positive cells as key drivers of the radiation‐induced accelerated aging‐like state that emerges progressively after genotoxic stress and show that the efficacy of senescence‐targeted interventions depends on when treatment is initiated, with implications for improving long‐term outcomes in cancer survivors.
Abstract
Genotoxic stress induced by cancer therapies is increasingly recognized as a driver of accelerated aging in long‐term cancer survivors, yet the mechanisms responsible for the emergence of age‐related dysfunction months to years after treatment remain poorly understood. Here, we use sublethal whole‐body irradiation as a model of systemic genotoxic stress to test whether senescent cells contribute to the progression of post‐therapy age‐related dysfunction and whether the benefits of senescent cell clearance depend on the timing of intervention. Using the INK‐ATTAC mouse model, we selectively eliminated p16Ink4a‐positive cells either early (1 month) or later (4 months) after irradiation. Early clearance had no effect on lifespan or functional outcomes. In contrast, delayed clearance markedly reduced frailty, improved neuromuscular and cognitive function, restored blood–brain barrier integrity, improved hepatic metabolic dysfunction, and increased median survival, with the survival benefit being most evident in female mice. Mechanistically, irradiation induced an early p21Cip1‐associated stress response and later accumulation of p16Ink4a‐positive cells in the brain and liver, which was associated with inflammation and tissue dysfunction. Clearance of p16Ink4a‐positive cells at the later stage attenuated these changes. Together, these findings identify p16Ink4a‐positive cells as key drivers of the radiation‐induced accelerated aging‐like state that emerges progressively after genotoxic stress. They also show that the efficacy of senescence‐targeted interventions depends on when treatment is initiated, with implications for improving long‐term outcomes in cancer survivors.
Radiotherapy can convert local tumor injury into systemic antitumor immunity, but this effect depends less on the nominal mode of cell death than on the tissue state that follows irradiation. This narrative review reframes radiation-induced regulated cell death around four functional outputs: antigen preservation, prod...
Xiao-Dong Wang, Wei Gao, Qian-Qian Wang et al.· Cancer Letters· 0 citations
ABSTRACT Aging is associated with functional decline and reduced regenerative capacity in the brain, is also the strongest risk factor for ischemic stroke, which remains a leading cause of mortality and long‐term disability worldwide, and is associated with impaired functional recovery. Here, we investigated whether sh...
Paula R. Mallavibarrena, Gerardo Martín-López, Jorge Rodríguez-Morales et al.· Aging Cell· 0 citations
The geroncogenic shift framework provides a conceptual basis for linking aging biology with tumor evolution and for developing more selective approaches to senescence-directed therapy.
Yu-Bo Zhang, Yue Han, Pin-Zhi Hou et al.· Frontiers in Pharmacology· 0 citations
Overall, current data support a context-dependent role for persistent senescence in treatment resistance, but do not establish TIS as a universal or independent cause of therapeutic failure.
ABSTRACT The molecular mechanisms linking type 2 diabetes to increased neurodegenerative risk remain poorly defined. Given the critical involvement of microglial dysfunction in neurodegeneration, we constructed a temporal single‐cell atlas integrating transcriptomic and epigenomic profiles of microglia from diabetic (d...
Ji-Zhou Zhang, Tsz-Kwan Yau, Joyce Tse et al.· Advancement of science· 0 citations